Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer’s disease and vascular cognitive impairment

Fig. 1

Plasma d16:1 S1P and S1P ratios were altered in a cohort of dementia patients. a d16:1 S1P, b d17:1 S1P, c d18:0 S1P, and d d18:1 S1P in nM were plotted across the diagnosis groups. e d18:1 to d16:1 S1P ratio was plotted across diagnosis groups and shown on a log-10 scale for better visualization of the spread of datapoints. Bars are expressed as median ± IQR. Pairwise comparisons were determined by Kruskal-Wallis test followed by post hoc Dunn’s tests, *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193